Diagnostics start-up STAT-Dx has sealed CE approval for its syndromic testing platform DiagCORE and the first assay, the DiagCORE Respiratory Panel 1, based on results of evaluation trials that will be presented at the European Congress of Clinical Microbiology and Infectious Diseases conference in Madrid in late April.
STAT-Dx's DiagCORE point-of-care platform is designed to test for the presence or absence of multiple pathogens that may cause clinical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?